Bitget App
Trade smarter
MarketsTradeFuturesEarnSquareMore
NEAR Trades at $1.86 as Price Holds Above Key $1.80 Support With Lower Levels Mapped Ahead

NEAR Trades at $1.86 as Price Holds Above Key $1.80 Support With Lower Levels Mapped Ahead

CryptonewslandCryptonewsland2025/11/23 20:18
By:by Vee Peninah
  • NEAR trades at $1.86 and remains above the $1.80 support level, which forms the chart’s most critical boundary.
  • A break below $1.80 aligns with a projected technical path toward $1.40, $1.20, and possibly $1.00.
  • The current range stretches between $1.80 support and $1.90 resistance, with price movement confined within this narrow band.

NEAR Protocol traded near a critical area on the daily chart after recording a 1.5% increase within the past 24 hours. The asset moved around $1.86 during the session, and the chart placed strong focus on the $1.80 support zone. This level formed one of the most important markers in the current structure, and price movement remained tightly aligned with it. 

Notably, the chart outlined a series of dotted paths that reflected several potential reactions if the price tested or failed to hold this support. These paths shaped the broader framework of the analysis, and they placed emphasis on the technical boundary that separated the current range from the lower levels around $1.00.

Key Levels Shape Market Structure

The $1.90 resistance level framed the upper boundary of the immediate range, and the price moved between this zone and the $1.80 support during the latest sessions. The chart showed repeated reactions around these levels over several months, and this history added context to the asset’s present position . However, the $1.80 area gained the most attention, as a break below it aligned with a clear technical path.

The dotted projections indicated that a move under this support could guide the price toward the next structured band. This zone appeared near $1.40, and the chart displayed several possible retests around that level before continuation. This transition illustrated how the price could travel through the marked regions based on past movement and current compression.

Projected Path Extends Below Immediate Range

Below the $1.40 area, the chart highlighted another structured zone near $1.20. The dotted lines showed multiple potential reactions along the way, and these steps connected the higher structure to the most distant projection near $1.00. The $1 target stood out as the final level in the illustrated sequence, and the chart placed a clear visual reference on its significance.

NEAR Protocol $NEAR must hold $1.80. Break it, and the chart points to $1 next. pic.twitter.com/5hMO8PQstf

— Ali (@ali_charts) November 23, 2025

The dotted moves also suggested that the lower range could form several temporary pauses before each adjustment. This setup helped outline how price transitions may unfold if the asset left its current band.

NEAR Holds Above $1.80 Amid Steady Daily Trading Range

NEAR’s position above $1.80 continued to define the short-term view as the asset fluctuated within the narrow daily range. The price action followed a steady pattern, and the current structure kept all attention on whether the support would hold.

Moreover, the 24-hour performance reflected modest strength, and the price increased by 1.5% while Bitcoin parity rose by 1.3%. These combined elements linked the immediate levels, the wider projections, and the current session’s movement into one sequence that framed the asset’s technical landscape.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

- Germany's SolarPlus Forum 2025 emphasized legislative clarity, funding innovation, and cross-sector collaboration to accelerate solar adoption amid evolving energy policies. - Outdated regulations and permitting hurdles were highlighted as barriers, with calls to align Bundestag reforms with market demands like gas surcharge removal by 2026. - Cement industry growth (5.7% CAGR) and green innovations support infrastructure needs, though energy cost volatility and compliance challenges persist. - Internati

Bitget-RWA2025/11/23 20:48
Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats